Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Denisa Weiser Drozdkova"'
Autor:
Petra Luzna, Denisa Weiser Drozdkova, Pavla Flodrova, Katarina Ondruskova, Ivo Uberall, Jiri Minarik, Zdenek Kolar, Katerina Smesny Trtkova
Publikováno v:
Biomedical Papers, Vol 167, Iss 1, Pp 43-49 (2023)
Aims. The aim of this study was to compare the expression profile of selected DNA methyltransferases and global DNA methylation status in patients with different phases of multiple myeloma (MM) . For the analysis, different cellular populations inclu
Externí odkaz:
https://doaj.org/article/da9369f7aa9d4fa88aba3942419199aa
Publikováno v:
Current Oncology, Vol 28, Iss 3, Pp 2087-2096 (2021)
Multiple myeloma (MM) is a malignant disease of the plasma cells representing approximately 10% of all hemato-oncological diseases. Detection of the disease is most probable at around 65 years of age, and the average survival of patients is estimated
Externí odkaz:
https://doaj.org/article/b3f16697d8d94578ae4e66994d7f6b68
Publikováno v:
Current Oncology, Vol 28, Iss 193, Pp 2087-2096 (2021)
Current Oncology
Current Oncology
Multiple myeloma (MM) is a malignant disease of the plasma cells representing approximately 10% of all hemato-oncological diseases. Detection of the disease is most probable at around 65 years of age, and the average survival of patients is estimated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dca8cb9fe2ed23ad5133b6e1ea7619ba
https://www.mdpi.com/1718-7729/28/3/193
https://www.mdpi.com/1718-7729/28/3/193
Autor:
Katerina Smesny, Trtkova, Petra, Luzna, Denisa Weiser, Drozdkova, Katerina, Cizkova, Lucie, Janovska, Jan, Gursky, Dana, Prukova, Ivo, Frydrych, Marian, Hajduch, Jiri, Minarik
Publikováno v:
Molecular Medicine Reports. 26
Gene inactivation of the cyclin‑dependent kinase inhibitors p16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d805e09ef72e152fb2839bb9dde4d819
https://doi.org/10.3892/mmr.2022.12837
https://doi.org/10.3892/mmr.2022.12837
Multiple myeloma (MM) is a biologically heterogenic disease with adequate wide spectrum of chromosomal, genetic and epigenetic changes. Epigenetic modifications can influence gene activity without changing the DNA sequence. There are biochemical modi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bf9044627c4d2e48332bd426bc655b7
https://doi.org/10.9734/bpi/nfmmr/v5/11646d
https://doi.org/10.9734/bpi/nfmmr/v5/11646d
